Effect of characteristics of women on attendance in blind and non-blind randomised trials: Analysis of recruitment data from the EPHT Trial

BMJ Open

Volumn 6, Issue 10, 2016, Pages

  Veerus, Piret ^a   Fischer, Krista ^b   Hemminki, Elina ^c   Hovi, Sirpa Liisa ^c   Hakama, Matti ^d  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d FINNISH CANCER REGISTRY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; EDUCATION; ESTONIA; FEMALE; HEALTH STATUS; HORMONAL THERAPY; HUMAN; INFORMED CONSENT; MEDICAL EXAMINATION; MULTICENTER STUDY; PHYSICIAN; POSTMENOPAUSE; PRIMARY PREVENTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE; SMOKING; STOMACH PAIN; DOUBLE BLIND PROCEDURE; EPIDEMIOLOGY; ESTROGEN THERAPY; MIDDLE AGED; PATIENT ATTITUDE; PATIENT PARTICIPATION; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

DOUBLE-BLIND METHOD; ESTONIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INFORMED CONSENT; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; POSTMENOPAUSE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84992383132     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-011099     Document Type: Article

References (15)

1. Wood L, Egger M, Gluud LL, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5.
2. Feys F, Bekkering GE, Singh K, et al. Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups? Syst Rev 2014;3:14.
3. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
4. Hrobjartsson A, Emanuelsson F, Skou Thomsen AS, et al. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and non-blind sub-studies. Int J Epidemiol 2014;43:1272-83.
5. Kunz R, Vist G, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 2007;(2):MR000012.
6. Hemminki E, Hovi SL, Veerus P, et al. Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapy. J Clin Epidemiol 2004;57:1237-43.
7. Veerus P, Fischer K, Hakama M, et al. EPHT Trial. Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial. BMC Med Res Methodol 2012;12:44.
8. Veerus P, Hovi SL, Fischer K, et al. Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]. Maturitas 2006;55:162-73.
9. Veerus P, Fischer K, Hovi SL, et al. Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]. Am J Obstet Gynecol 2006;195:62-71.
10. Veerus P, Fischer K, Hovi SL, et al. Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial. BMC Womens Health 2008;8:5.
11. Hovi SL. Preventive Trial on Postmenopausal Hormone Therapy in Estonia. https://tampub.uta.fi/bitstream/handle/10024/67592/ 951-44-6629-2.pdf?sequence=1 (accessed 27 Nov 2015).
12. Jewell NP. Statistics for epidemiology. 1st ed. London: Chapman & Hall/CRC, 2003.
13. Kennedy-Martin T, Curtis S, Faries D, et al. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 2015;16:495.
14. Loudon K, Treweek S, Sullivan F, et al. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 2015;350:h2147.
15. Zwarenstein M, Treweek S, Gagnier JJ, et al. for the CONSORT and Pragmatic Trials in Healthcare (Practihc) groups. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390.